Results 171 to 180 of about 128,749 (296)

Successful revascularization of an occluded renal artery after prolonged anuria [PDF]

open access: bronze, 1989
Paul G. Perona   +3 more
openalex   +1 more source

Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract Recognition of benefits and adverse effects of therapies in earlier clinical trial phases could improve the safety, efficiency, and cost of clinical trials. Using four clinical trials representing a diverse set of diseases and drug classes (EXSCEL: exenatide/GLP‐1 RA, SUGAR‐DM‐HF: empagliflozin/SGLT2i, PRADA: epirubicin/anthracycline, and ...
Jessica Chadwick   +17 more
wiley   +1 more source

Determinants of I O-year Survival after Primary Myocardial Revascularization

open access: green, 1985
Delos M. Cosgrove   +8 more
openalex   +2 more sources

Leveraging Point‐Of‐Care Ultrasound to Diagnose a Rare Arterial Occlusive Thrombus in a Child: A Case Study

open access: yesJournal of Clinical Ultrasound, EarlyView.
This case report illustrates the successful use of ultrasound imaging of arterial thrombosis in a child following orthopedic surgery, where regular diagnosis was difficult due to the presence of metallic orthopedic frames. ABSTRACT Pediatric arterial thromboembolism is an extremely rare and serious complication, especially rare when it is noncatheter ...
Vrushali C. Ponde   +4 more
wiley   +1 more source

Reduction of blood utilization during myocardial revascularization

open access: bronze, 1989
Wulf Dietrich   +4 more
openalex   +1 more source

INTRAVENOUS LABETALOL FOR BLOOD PRESSURE REDUCTION FOLLOWING MYOCARDIAL REVASCULARIZATION [PDF]

open access: bronze, 1987
Donald S. Prough   +3 more
openalex   +1 more source

Atypical Wounds in Chronic Graft‐Versus‐Host Disease and Peripheral Arterial Disease Caused by Tyrosine Kinase Inhibitors

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT The term “atypical wounds” primarily refers to lesions with immunological or cancerous etiologies. However, these wounds can also be drug‐induced. We report about a 32‐year‐old man with a 6‐year history of chronic myelogenous leukemia (CML) and chronic graft‐versus‐host disease (cGvHD) following an HLA‐compatible allogeneic stem cell ...
E. K. Stuermer   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy